TERF1

TERF1
Emw · CC BY-SA 3.0 · source
Name	TERF1
Uniprot	P54274
Organism	Homo sapiens

TERF1 TERF1 is a human telomeric repeat-binding factor involved in telomere length maintenance and chromosome end protection. It participates in shelterin-mediated telomere capping, influences replication fork progression at telomeric DNA, and modulates telomerase access. TERF1 has been studied in contexts ranging from cellular senescence to cancer, with connections to DNA damage response pathways and chromosomal stability.

Function

TERF1 binds double-stranded telomeric repeats to regulate telomere length and protect chromosome ends, coordinating with factors that mediate DNA repair, replication, and recombination. It limits telomerase action at telomeres, influences replication fork stability in association with proteins implicated in homologous recombination, and contributes to chromosome segregation by interacting with mitotic regulators. TERF1 activity impacts cellular senescence programs observed in studies involving replicative lifespan, oncogene-induced stress, and organismal aging models.

Structure and Domains

TERF1 is characterized by a C-terminal Myb-type DNA-binding domain that recognizes TTAGGG repeats and an N-terminal dimerization and protein-interaction region. Structural studies have resolved the Myb domain bound to telomeric DNA and revealed interfaces mediating homo-dimerization and recruitment of shelterin components. The modular architecture enables TERF1 to engage both sequence-specific binding and multivalent interactions with chromatin-associated factors implicated in chromosome end protection.

Regulation and Expression

TERF1 expression is controlled transcriptionally and post-translationally by signaling pathways and cell-cycle regulators; modulation occurs through phosphorylation, ubiquitination, and proteasomal turnover during S phase and mitosis. Key regulatory inputs include kinases and ubiquitin ligases that also participate in checkpoint control and replication stress responses described in studies linking DDR kinases to telomere maintenance. Tissue-specific expression patterns and developmental regulation have been examined in mammalian models and invertebrate systems to elucidate roles in proliferative tissues and stem cell compartments.

Interactions and Complexes

TERF1 forms the core of shelterin assemblies through interactions with telomere-associated factors that orchestrate telomeric architecture and signaling. It directly associates with proteins implicated in telomere capping, replication, and recombination, integrating with complexes that contain proteins studied in chromosomal stability research. TERF1 also engages with factors involved in nucleosome remodeling, checkpoint activation, and ubiquitin-mediated proteolysis, linking telomeric chromatin state to broader nuclear pathways analyzed in cell-cycle and DNA damage studies.

Role in Telomere Biology and Aging

TERF1 influences telomere length homeostasis, telomeric DNA replication, and the onset of replicative senescence documented in cell culture models and organismal aging research. By restricting telomerase access and coordinating replication fork progression through telomeric repeats, it contributes to telomere shortening dynamics observed in somatic tissues and stem cell niches. Altered TERF1 function impacts chromosome stability and has been implicated in age-related phenotypes in experimental models that probe links between telomere dysfunction, genome instability, and aging-related disorders.

Clinical Significance and Disease Associations

Alterations in TERF1 function or regulation have been associated with genomic instability syndromes, cancer predisposition, and telomere biology disorders investigated in oncological and hematological contexts. Changes in TERF1-mediated telomere protection can potentiate chromosomal aberrations noted in tumor samples and influence responses to replication stress-targeted therapies. Research into TERF1 intersects with translational studies of telomere maintenance mechanisms relevant to diagnostic biomarkers and potential therapeutic strategies in malignancies and telomeropathies.

Elizabeth Blackburn Carol W. Greider Jack W. Szostak Shinya Yamanaka Harold Varmus Bert Vogelstein Eric S. Lander James Watson Francis Crick Rosalind Franklin Linus Pauling Paul Nurse Rita Levi-Montalcini Sydney Brenner John Sulston Craig Venter Kary Mullis Andrew Fire Craig Mello Phillip A. Sharp Richard J. Roberts Stanley B. Prusiner Tim Hunt Michael Bishop Harold E. Varmus Rudolf Jaenisch Konrad Bloch Christian de Duve Ada Yonath Har Gobind Khorana Thomas Cech Ada Yonath Aaron Ciechanover Avram Hershko Irwin Rose Jeffrey C. Hall Michael Rosbash Michael W. Young Nobel Prize Cold Spring Harbor Laboratory Max Planck Society Howard Hughes Medical Institute National Institutes of Health European Molecular Biology Laboratory Wellcome Trust Salk Institute Broad Institute Massachusetts Institute of Technology Harvard University Stanford University University of Cambridge University of Oxford Karolinska Institute University of California, San Francisco Rockefeller University Memorial Sloan Kettering Cancer Center Dana-Farber Cancer Institute Mayo Clinic Johns Hopkins University University of Tokyo Institut Pasteur Weizmann Institute of Science Cold Spring Harbor Laboratory Press Nature (journal) Science (journal) Cell (journal) Proceedings of the National Academy of Sciences EMBO Journal Molecular Cell The Lancet New England Journal of Medicine Proceedings of the Royal Society B Genes & Development Journal of Cell Biology Nucleic Acids Research Oncogene Cancer Research

Category:Proteins